Zika virus (ZIKV) was first isolated in 1947 and until 2007, the only reported outbreak had been in Micronesia ([@CIT0016]). In early 2015, Brazil reported the first case of ZIKV in a Northeastern state ([@CIT0026]) with rapid expansion to all regions of the country. By 2017, 3,754 probable cases of ZIKV had been registered with an incidence rate of 1.8 cases/1,000 inhabitants ([@CIT0003]). Between November 2015 and May 2017, there were more than 13,000 suspected cases associated with changes in growth and development in newborns, with 2,722 cases confirmed and 3,245 cases still under investigation ([@CIT0004]). Currently, ZIKV is circulating in all Brazilian states.

ZIKV is transmissible primarily by mosquitoes, but other types of transmission have already been described, such as by sexual routes ([@CIT0019]). In mosquitoes, a mechanism that may contribute to virus survival through adverse conditions is vertical transmission (VT), when infected females pass the virus to her eggs/embryos and the resulting offspring ([@CIT0011], [@CIT0024]). ZIKV is a member of the Flaviviridae family related to arboviruses such as West Nile virus, yellow fever virus and dengue virus (DENV) that can be transmitted from one mosquito generation to the next via VT ([@CIT0502], [@CIT0012], [@CIT0021]).

The most important mechanism for the spread of ZIKV, and the resulting human disease, is the typical horizontal transmission via the bite of an infected *Aedes aegypti*, the primary vector ([@CIT0016]). However, it is essential to understand if infected *Ae. aegypti* are capable of VT of ZIKV. This may serve as a mechanism for maintaining ZIKV in the vectors in the absence of available or susceptible vertebrate hosts. In this report, we utilized newly colonized Brazilian *Ae. aegypti* and demonstrated the VT of ZIKV from orally infected female mosquitoes to their progeny, and illustrated that ZIKV infection also constrains the normal mosquito development.

Materials and Methods {#s1}
=====================

Ethic Approval {#s2}
--------------

This study was conducted in accordance with recommendations from the Manual for the Use of Animals (FIOCRUZ, Ministry of Health of Brazil, National decree, Nr. 3179) and approved by the Ethics Committee for the Use of Animals of Fundação Oswaldo Cruz (FIOCRUZ, Ministry of Health of Brazil, Nr. L-1715). This protocol was authorized by the Ethics in Animal Use Committee of Tropical Medicine Foundation Dr. Heitor Vieira Dourado, Manaus -- AM, Brazil (protocol number 002380/2016).

*Ae. aegypti* Collection {#s3}
------------------------

Two thousand five hundred eggs were collected in the field using ovitraps in a ZIKV endemic area of Manaus, the capital city of the state of Amazonas, and allowed to hatch, all larvae were identified as *Ae. aegypti*. A subsample of 100 randomly chosen larvae was verified to be ZIKV and DENV-free by quantitative polymerase chain reaction (qPCR). The resulting virus-free adult mosquitoes were reared as described previously ([@CIT0013]) and used to establish a third--fourth generation to conduct ZIKV infection experiments.

ZIKV and Mosquito Infection {#s4}
---------------------------

A human isolate of ZIKV from the State of São Paulo, Brazil (ZIKV/H. sapiens/Brazil/SPH/2015) was used to infect the mosquitoes ([@CIT0009]). Virus stocks were passaged and maintained in an *Aedes albopictus* clone C6/36 cell line (ATCC - CRL-1660) as previously described ([@CIT0013]). Virus titration followed the TCID50 method ([@CIT0501]). Two hundred, 3--5 d old, inseminated *Ae. aegypti* females were infected orally via glass feeding devices filled with ZIKV-infected C6/36 cell culture supernatant re-suspended in 2:1 fresh mouse blood with heparin ([@CIT0013]). The ZIKV titer of 5 × 10^5^ PFU/ml was determined using Vero cell line by plaque assay. A control group of *Ae. aegypti* females was treated using the same conditions as the tested ZIKV-infected female group, but fed with a normal bloodmeal. Mosquitoes were allowed to feed for 1 h and 150 fully engorged females from each group were separated and maintained on 10% glucose solution ad libitum.

VT of ZIKV to the *Ae. aegypti* Progeny {#s5}
---------------------------------------

Four days post infection (4 d.p.i.), 30 mosquitoes were randomly selected from the two experimental groups. Each mosquito was placed into a small individual cage and allowed to oviposit over the following 3 d. On the 7 d.p.i., the parental infected mosquitoes were individually evaluated for ZIKV by qPCR ([@CIT0023]). Four days after the oviposition, eggs from positive females (ZIKV-infected) and control mosquitoes were separated into two groups and placed in small cups to observe individual hatching. The resulting F1 larvae (L3--L4) were randomly placed into sixty groups of 10 (*n* = 600). Twenty individuals at each distinct developmental stage (larvae, pupae, and adults, *n* = 200) of these two groups were assayed for ZIKV by qPCR as 10 single pools. Individuals of each stage were chosen randomly regardless of sex.

Effect of VT-ZIKV on *Ae. aegypti* Developmental Stages {#s6}
-------------------------------------------------------

Thirty parentally ZIKV-infected *Ae. aegypti* were randomly selected and allowed to oviposit in order for us to evaluate the number of laid eggs, time to hatch, and period of larval development until pupation of the infected F1 progeny. Larvae and pupae were counted every day since the eggs hatched. The data were compared with the control group. The two groups were kept in the same room, and in the identical controlled conditions (temperature \[28°C\], humidity \[80%\], food availability, and breeding container).

Viability of VT-ZIKV to the Progeny {#s7}
-----------------------------------

Fifteen F1 VT-ZIKV *Ae. aegypti* adults were grouped into three pools of five individuals and macerated in L-15 medium with 1% Penicillin/Streptomycin (10,000 U/ml), 2.5 g/ml Amphotericin B and 2% FBS, cultivated in C6/36 cells for 5 d as described above for observation of ZIKV growth and cytopathic effect (CPE; [@CIT0500]).The ZIKV-free mosquitoes were used as negative control and inoculated in cell culture at the same time as test mosquitoes.

VT-ZIKV Detection and Quantification by qPCR {#s8}
--------------------------------------------

Samples were processed for RNA extraction (QIAamp viral RNA Mini kit, Qiagen, Hilden, Germany) ([@CIT0017]). Reverse transcription with cDNA production was carried out using a random primer and M-MLV enzyme, and subsequent TaqMan-based qPCR assay for ZIKV (primers set ZIKV 1086 and ZIKV 1162c) ([@CIT0017], [@CIT0023]). Standard curve used was from gBlocks Gene Fragments dilutions, range 30,000 to 3 copies.

Statistical Analyses {#s9}
--------------------

Shapiro Wilk and two-tailed Student's *t*-tests were used to evaluate significance among the groups in relation to mean numbers of laid eggs. Differences in numbers of hatched eggs among groups were evaluated using two-tailed χ ^2^ or Fisher's tests. Period of time to egg hatching and development time of the larvae until pupation were analyzed using a Kaplan-Meier (log-rank) analysis, *P* values ≤ 0.05 were considered significant. Statistical analysis was performed in GraphPad Prism, version 5.00 (San Diego, CA) and Stata (Stata Statistical Software, version 13.0).

Results {#s10}
=======

ZIKV Infection of the Amazonian *Ae. aegypti* and Vertical and Trans-stadial Transmission in the Progeny {#s11}
--------------------------------------------------------------------------------------------------------

The Amazonian *Ae. aegypti* were very susceptible to ZIKV infection. Individual qPCR analysis of the 7 d.p.i mosquitoes revealed an infection rate (IR) of 96.7% (29/30) with a median (md) = 1.3 × 10^6^ ZIKV cDNA copies/mosquito. The analysis of a total of 600 F1 individuals in 20 pools per life stage demonstrated high filial infection rates (FIR) due to VT of ZIKV as follows: 55% in larvae (11 out of 20 pools) md = 2.5 × 10^2^ ZIKV cDNA copies, 50% in pupae (10 out 20 pools) md = 1.9 × 10^2^ ZIKV cDNA copies and 70% in adults (14 out of 20 pools) md = 1.7 × 10^2^ ZIKV cDNA copies. Trans-stadial transmission (i.e., presence of ZIKV from one life stage to the next), showed the minimum filial infection rates (MFIR) to be 1:18 in larvae, 1:20 in pupae, and 1:14.3 in adults ([Table 1](#T1){ref-type="table"} and [Fig. 1](#F1){ref-type="fig"}).

###### 

ZIKV infection of *Aedes aegypti* and F1 progeny

  Parental                                   F1 progeny                              
  -------------- --------------------------- ------------ ---- ------------ -------- ---------------------------
                                             Larvae       20   11/20 (55)   1:18.2   2.5 × 10^2^ ± 2.1 × 10^3^
  29/30 (96.7)   1.3 × 10^6^ ± 1.4 × 10^7^   Pupae        20   10/20 (50)   1:20.0   1.9 × 10^2^ ± 8.3 × 10^2^
                                             Adult        20   14/20 (70)   1:14.3   1.7 × 10^2^ ± 2.9 × 10^2^

^*a*^Filial infection rate.

^*b*^Minimum filial infection rate.

![Schematic representation of the experimental design.](tjz110f0001){#F1}

Effect of VT-ZIKV and Trans-stadial Infection in the Development of Amazonian *Ae. aegypti* {#s12}
-------------------------------------------------------------------------------------------

Out of the 30 selected parental ZIKV-infected *Ae. aegypti*, 29 of these laid 2,853 eggs while the same number of the control mosquitoes laid 2,672 eggs (one female in each group died before laying eggs), of these 2,215 and 2,214 hatched, respectively. The mean number of laid eggs by each ZIKV-infected and control mosquitoes were 98.36 (±22.20) and 92.14 (±26.44), respectively, with no significant difference in oviposition rates ([Fig. 2a](#F2){ref-type="fig"}). The eclosion rates (number of eggs hatched/number of eggs laid) were 82.9% for control and 77.6% for VT-ZIKV-infected mosquitoes, which was statically significant (*P* \< 0.001) ([Fig. 2b](#F2){ref-type="fig"}).

![Evaluation of number of eggs laid and hatched for *Ae. aegypti* infected with ZIKV. (a) Mean number of eggs laid; (b) Egg hatch rate.](tjz110f0002){#F2}

Fitness Costs of VT-ZIKV-infected *Ae. aegypti* Progeny {#s13}
-------------------------------------------------------

The fitness costs of the VT-ZIKV-infected F1 *Ae. aegypti* progeny were measured using survivorship curves following the Kaplan-Meier method and tested for significance by Log-rank test (*P* \< 0.05). The number of eggs hatched daily and the period of larval development to pupae was compared between the VT-ZIKV-infected and control mosquitoes. Differences in the hatch rate occurred in the first 10 d. The VT-ZIKV group had the slowest hatching and the larval development period (eclosion to pupation) compared with control group (*P* \< 0.001; [Fig. 3a](#F3){ref-type="fig"} and [b](#F2){ref-type="fig"}).

![The fitness cost of *Ae. aegypti* progeny derived from ZIKV-infected mosquitoes compared with the control. (a) Analysis of number of eggs hatched daily illustrates difference in the hatch rate happened in the first 10 d, ZIKV group has the slowest hatching. (b) Larval development time from hatching to pupation was longer for ZIKV-infected individuals. (Kaplan-Meier \[log-rank\] analysis, *P* values ≤ 0.05 were considered significant).](tjz110f0003){#F3}

Viability of VT-ZIKV of the *Ae. aegypti* Progeny {#s14}
-------------------------------------------------

The supernatant of macerated F1 adult mosquitoes was evaluated for viable ZIKV by cell cultures. Orally infected VT-ZIKV *Ae. aegypti* F1 of the progeny was able to infect C6/36 cell cultures and CPE was observed at 5 d.p.i. ([Fig. 4](#F4){ref-type="fig"}).

![Light microscopy of uninfected and ZIKV-infected C6/36 cell monolayers, 5 days post inoculum. (a) Uninfected C6/36 cells in a typical monolayer. (b) C6/36 cultivated with the supernatants of the adult F1 progeny derived from the ZIKV-infected parental mosquitoes reveal significant cytopathic effect with the formation of large syncytia.](tjz110f0004){#F4}

Discussion {#s15}
==========

The first two cases of ZIKV were confirmed in Manaus, State of Amazonas, in January 2016. In 2017, 1 yr later, the city confirmed 4,418 Zika cases including 500 pregnant women and five microcephaly cases in newborns ([@CIT0020]). It is astonishing how quickly ZIKV spread through the city and improving our understanding of ZIKV dispersal and transmission is critical. Today, it is well known that ZIKV behaves differently from other Flaviviruses since it is capable of being transmitted sexually between humans via its presence in body fluids such as semen and urine, and in the female genital tract ([@CIT0001]).

In cities like Manaus, several factors such as unplanned urban expansion, irregular or absence of waste collection, and poor socioeconomic conditions contribute to the development of breeding sites and subsequent increases in the *Ae. aegypti* populations. Previously, only two studies, using mosquitoes from Rio de Janeiro, a Southeastern city, described the susceptibility of Brazilian *Ae. aegypti* to ZIKV. The first study reports a high infection and disseminated IR ([@CIT0010]), which is similar to our findings. The second study reports a high IR, but with low levels of disseminated infection in recently colonized *Ae. aegypti* ([@CIT0006]). Since we worked with a mosquito population from Manaus, a Northern city, these differences may reflect the genetic or physiological variability in the permissiveness of these geographically different *Ae. aegypti* populations.

The Amazonian *Ae. aegypti* mosquitoes are highly susceptible to oral ZIKV infection and we verified the VT to their progeny. The MFIR of the larvae and adults of the *Ae. aegypti* was greater than other studies describing VT in other populations ([@CIT0025], [@CIT0007]). It is worth noting that, in the previous VT studies, the infections were artificially initiated via intra-thoracic injection by syringe, however, our study was the first one to demonstrate the VT-ZIKV by natural oral infection of the parental mosquitoes. Additionally, this study used third and fourth generations of *Ae. aegypti* from eggs collected in the field, infected with a ZIKV strain that is naturally circulating in the country. In 2016, a study in Rio de Janeiro Brazil showed for the first time that among 963 *Ae. aegypti* males only one was naturally infected with ZIKV by venereal and/or VT ([@CIT0011]). Certainly, this experimental model is a more accurate reflection of how efficiently VT-ZIKV mosquitoes occur in an endemic region.

Many studies have shown that pathogens, including arboviruses transmitted by insects, can affect vector fitness mainly related to their physiology ([@CIT0022], [@CIT0015]). Decreased fecundity and fertility of DENV infected parental *Ae. aegypti* and lengthening of the larval development period of VT-DENV infected progeny have been reported ([@CIT0014], [@CIT0018]). In addition, our study shows that ZIKV infection also alters *Ae. aegypti*'s physiology, e.g., by delaying hatching of the eggs and by changing the larvae stage. Essentially, there is no significant difference in the number of laid eggs by ZIKV-infected parental *Ae. aegypti* compared to the noninfected mosquitoes, but a decrease in egg eclosion rate occurred, and the larval development period of the VT-ZIKV-infected progeny increased.

Our results show that ZIKV infection in *Ae. aegypti* has the potential to modify the mosquito life cycle by increasing the time of two major life stages: egg eclosion and larval development. The data reported here suggest that VT of ZIKV to progeny from naturally infected females may have a critical role in the dissemination and maintenance of the virus circulating in the vector.

VT occurs, but with a small number of cDNA viral copies in VT-ZIKV-infected progeny, similar to a study with VT-DENV-1 in *Ae. aegypti* and *Ae. albopictus* ([@CIT0005]). These are important aspects that need to be explored further in the context of urban vector-borne disease dispersal since they can have a significant epidemiological impact. The developmental delays in immature vector mosquitoes and the decrease in the eggs hatching rate induced by ZIKV infection may make the mosquito more vulnerable to vector control of immature stages. This kind of information about vector biology is important for directing interventions in vector control; and this can influence the dispersion and incidence of the disease. If *Ae. aegypti* mosquitoes emerge already infected and are capable of transmitting ZIKV to humans, the potential risk is dramatically increased, especially for populations already bearing the brunt of ongoing epidemics. Thus, it is necessary to develop complementary studies to evaluate vector competence of ZIKV-infected progeny, as well as gaining a better understanding of how many generations ZIKV can be maintained for via VT in field populations of permissive vectors.
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